ADAR1 Capital Management, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.1T
Holdings
203
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (203 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | BNTXBIONTECH SE | 10,000 | $986.2M | 0.09% | |
| 102 | CTNMCONTINEUM THERAPEUTICS INC | 77,961 | $916.0M | 0.09% | |
| 103 | AVRANTERIS TECHNOLOGIES GLOBAL | 197,615 | $889.3M | 0.08% | |
| 104 | TECXTECTONIC THERAPEUTIC INC | 56,007 | $878.8M | 0.08% | |
| 105 | WVEWAVE LIFE SCIENCES LTD | 119,067 | $871.6M | 0.08% | |
| 106 | KVACKEEN VISION ACQUISITION CORP | 75,000 | $863.3M | 0.08% | Call |
| 107 | PHVSPHARVARIS N V | 34,124 | $851.4M | 0.08% | |
| 108 | NVCRNOVOCURE LTD | 64,000 | $826.9M | 0.08% | Call |
| 109 | LLYELI LILLY & CO | 1,000 | $763.0M | 0.07% | |
| 110 | LRMRLARIMAR THERAPEUTICS INC | 235,689 | $761.3M | 0.07% | |
| 111 | SRRKSCHOLAR ROCK HLDG CORP | 20,087 | $748.0M | 0.07% | |
| 112 | DNLIDENALI THERAPEUTICS INC | 51,516 | $748.0M | 0.07% | |
| 113 | BHVNBIOHAVEN LTD | 49,341 | $740.6M | 0.07% | Call |
| 114 | DYNDYNE THERAPEUTICS INC | 57,663 | $729.4M | 0.07% | Call |
| 115 | ACRSACLARIS THERAPEUTICS INC | 373,682 | $710.0M | 0.07% | |
| 116 | LITSLITE STRATEGY INC | 292,397 | $707.6M | 0.07% | |
| 117 | GOSSGOSSAMER BIO INC | 267,631 | $703.9M | 0.07% | Call |
| 118 | ARVNARVINAS INC | 82,591 | $703.7M | 0.07% | |
| 119 | SUPNSUPERNUS PHARMACEUTICALS INC | 14,418 | $689.0M | 0.06% | |
| 120 | DAYDAYFORCE INC | 10,000 | $688.9M | 0.06% | |
| 121 | MAZEMAZE THERAPEUTICS INC | 26,045 | $675.3M | 0.06% | |
| 122 | EWTXEDGEWISE THERAPEUTICS INC | 40,000 | $648.8M | 0.06% | |
| 123 | BABAALIBABA GROUP HLDG LTD | 3,578 | $639.5M | 0.06% | |
| 124 | GONGERON CORP | 456,176 | $625.0M | 0.06% | |
| 125 | OLMAOLEMA PHARMACEUTICALS INC | 61,200 | $599.1M | 0.06% | Call |
| 126 | SPRYARS PHARMACEUTICALS INC | 59,230 | $595.3M | 0.06% | |
| 127 | SYRESPYRE THERAPEUTICS INC | 34,051 | $570.7M | 0.05% | |
| 128 | AEXAAMERICAN EXCEPTIONALISM ACQU | 50,000 | $546.5M | 0.05% | |
| 129 | IDYAIDEAYA BIOSCIENCES INC | 20,000 | $544.2M | 0.05% | |
| 130 | LENZLENZ THERAPEUTICS INC | 11,619 | $541.2M | 0.05% | |
| 131 | NGNENEUROGENE INC | 30,633 | $530.9M | 0.05% | |
| 132 | BHFBRIGHTHOUSE FINL INC | 10,000 | $530.8M | 0.05% | |
| 133 | GTERAGLOBA TERRA ACQUISITION COR | 50,000 | $508.5M | 0.05% | |
| 134 | PHATPHATHOM PHARMACEUTICALS INC | 42,900 | $504.9M | 0.05% | |
| 135 | USFRWISDOMTREE TR | 10,000 | $502.7M | 0.05% | |
| 136 | KZRKEZAR LIFE SCIENCES INC | 124,967 | $487.4M | 0.05% | |
| 137 | KURAKURA ONCOLOGY INC | 55,000 | $486.8M | 0.05% | |
| 138 | ASMBASSEMBLY BIOSCIENCES INC | 18,947 | $485.0M | 0.05% | |
| 139 | KPRXKIORA PHARMACEUTICALS INC | 167,941 | $466.9M | 0.04% | |
| 140 | APLSAPELLIS PHARMACEUTICALS INC | 20,000 | $452.6M | 0.04% | |
| 141 | INSPINSPIRE MED SYS INC | 6,000 | $445.2M | 0.04% | |
| 142 | GBS1EURINTELLIGENT BIO SOLUTIONS IN | 426,433 | $435.0M | 0.04% | |
| 143 | SGRYSURGERY PARTNERS INC | 20,000 | $432.8M | 0.04% | |
| 144 | GPCRSTRUCTURE THERAPEUTICS INC | 15,200 | $425.6M | 0.04% | |
| 145 | AVTXAVALO THERAPEUTICS INC | 32,393 | $411.7M | 0.04% | |
| 146 | TENXTENAX THERAPEUTICS INC | 53,428 | $406.6M | 0.04% | |
| 147 | VTGNVISTAGEN THERAPEUTICS INC | 113,062 | $401.4M | 0.04% | |
| 148 | ORKAORUKA THERAPEUTICS INC | 20,840 | $400.8M | 0.04% | |
| 149 | GHGUARDANT HEALTH INC | 6,000 | $374.9M | 0.04% | |
| 150 | JDJD.COM INC | 10,000 | $349.8M | 0.03% | |
| 151 | ATYRATYR PHARMA INC | 482,300 | $347.9M | 0.03% | Put |
| 152 | LUNGPULMONX CORP | 214,497 | $347.5M | 0.03% | |
| 153 | CNTXCONTEXT THERAPEUTICS INC | 351,094 | $340.1M | 0.03% | |
| 154 | JAZZJAZZ PHARMACEUTICALS PLC | 2,500 | $329.5M | 0.03% | |
| 155 | AVTRAVANTOR INC | 25,000 | $312.0M | 0.03% | |
| 156 | ANSCAGRICULTURE & NAT SOL ACQ CO | 27,062 | $295.5M | 0.03% | |
| 157 | AKROAKERO THERAPEUTICS INC | 6,143 | $291.7M | 0.03% | |
| 158 | NRIXNURIX THERAPEUTICS INC | 31,200 | $288.3M | 0.03% | |
| 159 | PCAPPROCAP ACQUISITION CORP | 26,940 | $282.9M | 0.03% | |
| 160 | HRMYHARMONY BIOSCIENCES HLDGS IN | 10,245 | $282.4M | 0.03% | |
| 161 | RAREULTRAGENYX PHARMACEUTICAL IN | 9,000 | $270.7M | 0.03% | |
| 162 | CLYMCLIMB BIO INC | 133,530 | $268.4M | 0.03% | |
| 163 | BMRNBIOMARIN PHARMACEUTICAL INC | 4,900 | $265.4M | 0.02% | |
| 164 | VTYXVENTYX BIOSCIENCES INC | 81,600 | $253.8M | 0.02% | |
| 165 | ALMSALUMIS INC | 61,291 | $244.6M | 0.02% | |
| 166 | SAVACASSAVA SCIENCES INC | 81,000 | $235.7M | 0.02% | |
| 167 | TXMDTHERAPEUTICSMD INC | 209,210 | $224.9M | 0.02% | |
| 168 | KALAKALA BIO INC | 141,995 | $217.3M | 0.02% | |
| 169 | SPROSPERO THERAPEUTICS INC | 115,539 | $217.2M | 0.02% | |
| 170 | BCAXBICARA THERAPEUTICS INC | 13,705 | $216.4M | 0.02% | |
| 171 | IFRXINFLARX NV | 159,479 | $213.7M | 0.02% | |
| 172 | DAWNDAY ONE BIOPHARMACEUTICALS I | 28,023 | $197.6M | 0.02% | |
| 173 | HELPCYBIN INC | 33,278 | $196.0M | 0.02% | |
| 174 | CMPXCOMPASS THERAPEUTICS INC | 50,000 | $175.0M | 0.02% | |
| 175 | RXRXRECURSION PHARMACEUTICALS IN | 35,000 | $170.8M | 0.02% | |
| 176 | PEPGPEPGEN INC | 36,842 | $170.2M | 0.02% | |
| 177 | KPTIKARYOPHARM THERAPEUTICS INC | 25,000 | $163.5M | 0.02% | |
| 178 | VYGRVOYAGER THERAPEUTICS INC | 35,000 | $163.4M | 0.02% | |
| 179 | TARAPROTARA THERAPEUTICS INC | 35,223 | $153.2M | 0.01% | |
| 180 | SP4PACHIEVE LIFE SCIENCES INC | 47,800 | $150.6M | 0.01% | |
| 181 | CLOVCLOVER HEALTH INVESTMENTS CO | 48,300 | $147.8M | 0.01% | |
| 182 | FDMT4D MOLECULAR THERAPEUTICS IN | 16,712 | $145.2M | 0.01% | |
| 183 | PMVPPMV PHARMACEUTICALS INC | 101,008 | $141.4M | 0.01% | |
| 184 | GBIOGENERATION BIO CO | 22,144 | $135.5M | 0.01% | |
| 185 | CRBPCORBUS PHARMACEUTICALS HLDGS | 10,200 | $129.0M | 0.01% | |
| 186 | KALVKALVISTA PHARMACEUTICALS INC | 10,000 | $121.8M | 0.01% | |
| 187 | IOVAIOVANCE BIOTHERAPEUTICS INC | 50,000 | $108.5M | 0.01% | Call |
| 188 | OGNORGANON & CO | 10,000 | $106.8M | 0.01% | |
| 189 | SLNSILENCE THERAPEUTICS PLC | 18,643 | $96.8M | 0.01% | |
| 190 | ZNTLZENTALIS PHARMACEUTICALS INC | 50,000 | $75.5M | 0.01% | |
| 191 | TERNTERNS PHARMACEUTICALS INC | 10,000 | $75.1M | 0.01% | |
| 192 | STISOLIDION TECHNOLOGY INC | 13,500 | $62.6M | 0.01% | Call |
| 193 | ASPCRA SPAC III ACQUISITION CORP | 215,000 | $41.0M | 0.00% | |
| 194 | PHGEBIOMX INC | 77,656 | $40.8M | 0.00% | |
| 195 | SABSSAB BIOTHERAPEUTICS INC | 15,000 | $30.1M | 0.00% | |
| 196 | NERVMINERVA NEUROSCIENCES INC | 12,406 | $26.1M | 0.00% | |
| 197 | —MURAL ONCOLOGY PUB LTD CO | 11,855 | $24.5M | 0.00% | |
| 198 | IBIOIBIO INC | 27,000 | $22.4M | 0.00% | |
| 199 | PRQRPROQR THRAPEUTICS N V | 10,000 | $21.3M | 0.00% | |
| 200 | GUTSFRACTYL HEALTH INC | 13,097 | $20.8M | 0.00% |